We are live on !
Find out more
Axa Portfolio holdings
AUM
$91.9M
Turnover
57.14%
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.62%
5 Year Est. Return
+129.91%
10 Year Est. Return
+554.84%
AUM
$23B
AUM Growth
+$654M
(+2.9%)
Cap. Flow
+$6.71M
Cap. Flow % of AUM
Cap. Flow %
0.03%
Top 10 Holdings %
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$284M |
| 2 |
Deutsche Bank
DB
|
+$159M |
| 3 |
Norfolk Southern
NSC
|
+$108M |
| 4 |
HP
HPQ
|
+$92.2M |
| 5 |
Du Pont De Nemours E I
DD
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$161M |
| 2 |
Ford
F
|
+$87.9M |
| 3 |
Whirlpool
WHR
|
+$74M |
| 4 |
PNC Financial Services
PNC
|
+$72.9M |
| 5 |
Eastman Chemical
EMN
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.62% |
| 2 | Technology | 14.22% |
| 3 | Financials | 13.17% |
| 4 | Industrials | 11.49% |
| 5 | Energy | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Deutsche Bank
DB
$62.4B
| $494M | 2.15% |
12,925,746
+3,890,562
| +43% | +$159M |
2013 Q2
3 quarters
|
|
2
Apple
AAPL
$5.03T
| $421M | 1.83% |
21,964,600
-497,196
| -2% | -$9.46M |
2013 Q2
3 quarters
|
|
|
3
Verizon
VZ
$185B
| $366M | 1.59% |
7,685,725
+6,006,588
| +358% | +$284M |
2013 Q2
3 quarters
|
|
4
Pfizer
PFE
$174B
| $366M | 1.59% |
11,996,241
-513,606
| -4% | -$15.3M |
2013 Q2
3 quarters
|
|
5
Amgen
AMGN
$252B
| $352M | 1.53% |
2,851,939
+95,342
| +3% | +$11.6M |
2013 Q2
3 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$3.42T
| $345M | 1.5% |
12,419,899
+373,234
| +3% | +$10.9M |
2013 Q2
3 quarters
|
|
7
Oracle
ORCL
$396B
| $316M | 1.37% |
7,722,918
-264,396
| -3% | -$10.1M |
2013 Q2
3 quarters
|
|
8
Wells Fargo
WFC
$250B
| $300M | 1.3% |
6,022,005
-55,223
| -0.9% | -$2.57M |
2013 Q2
3 quarters
|
|
9
ExxonMobil
XOM
$770B
| $295M | 1.28% |
3,018,072
-122,343
| -4% | -$11.7M |
2013 Q2
3 quarters
|
|
10
Comcast
CMCSA
$82.6B
| $243M | 1.06% |
9,717,718
-220,834
| -2% | -$5.75M |
2013 Q2
3 quarters
|
|
11
Microsoft
MSFT
$3.88T
| $243M | 1.06% |
5,918,671
+156,500
| +3% | +$5.87M |
2013 Q2
3 quarters
|
|
12
Medtronic
MDT
$124B
| $242M | 1.05% |
3,935,285
+97,620
| +3% | +$5.69M |
2013 Q2
3 quarters
|
|
13
Johnson & Johnson
JNJ
$658B
| $214M | 0.93% |
2,174,922
-98,419
| -4% | -$9.12M |
2013 Q2
3 quarters
|
|
|
14
HP
HPQ
$25.9B
| $210M | 0.91% |
14,306,812
+6,854,870
| +92% | +$92.2M |
2013 Q2
3 quarters
|
|
15
CNH Industrial
CNH
$18.9B
| $209M | 0.91% |
20,910,777
+2,223,670
| +12% | +$21.4M |
2013 Q4
1 quarter
|
|
16
Merck
MRK
$369B
| $203M | 0.88% |
3,748,904
+1,548,373
| +70% | +$80.2M |
2013 Q2
3 quarters
|
|
17
UnitedHealth
UNH
$365B
| $193M | 0.84% |
2,353,884
-64,822
| -3% | -$4.88M |
2013 Q2
3 quarters
|
|
18
Northrop Grumman
NOC
$79.2B
| $184M | 0.8% |
1,495,100
+457,730
| +44% | +$54.2M |
2013 Q2
3 quarters
|
|
|
RTN
19
DELISTED
Raytheon Company
RTN
| $178M | 0.77% |
1,798,246
+535,246
| +42% | +$50.8M |
2013 Q2
3 quarters
|
|
20
Gilead Sciences
GILD
$212B
| $177M | 0.77% |
2,503,602
+921,616
| +58% | +$72.3M |
2013 Q2
3 quarters
|
|
21
Kroger
KR
$39.4B
| $171M | 0.75% |
7,854,714
+213,936
| +3% | +$4.26M |
2013 Q2
3 quarters
|
|
22
Booking.com
BKNG
$111B
| $170M | 0.74% |
3,568,875
+303,725
| +9% | +$15M |
2013 Q2
3 quarters
|
|
23
Chevron
CVX
$462B
| $170M | 0.74% |
1,427,240
-143,466
| -9% | -$16.7M |
2013 Q2
3 quarters
|
|
24
DELISTED
Discover Financial Services
DFS
| $169M | 0.74% |
2,912,084
-127,640
| -4% | -$7.15M |
2013 Q2
3 quarters
|
|
25
ConocoPhillips
COP
$185B
| $168M | 0.73% |
2,391,788
+374,894
| +19% | +$25.1M |
2013 Q2
3 quarters
|
|
Similar funds
HI
Axa's Q1 2014 Portfolio in Review
As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
- Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
- Axa added most to Verizon in Q1 2014, an estimated $284M increase.
- Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
- Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
- Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
- Axa opened 151 new positions and closed 141 in Q1 2014.
- Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.
Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.